Industry Verticals »

All Categories

Insights »

About TMR »

Psychotropic Drugs Market

Psychotropic Drugs Market (Drug Class: Antidepressants, Antipsychotics, Anxiolytics, Mood Stabilizers, Stimulants, Sedatives & Hypnotics, and Others; Drug Type: Branded and Generic; and Indication: Depression, Schizophrenia, Bipolar Disorder, Anxiety Disorders, Attention-Deficit/Hyperactivity Disorder (ADHD), Post-Traumatic Stress Disorder (PTSD), Obsessive-Compulsive Disorder (OCD), and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Psychotropic Drugs Market Outlook

The global psychotropic drugs market size was valued at US$ 23.1 Bn in 2025 and is projected to reach US$ 41.2 Bn by 2036, expanding at a CAGR of 5.4% from 2026 to 2036. The market growth is driven by rising prevalence of mental health disorders, advancements in drug development, and favorable reimbursement and insurance coverage.

Market Size & Highlights

  • The psychotropic drugs market reached US$ 23.1 Bn in 2025.
  • The market is expected to climb to US$ 41.2 Bn by 2036.
  • The psychotropic drugs industry is anticipated to expand at a CAGR of 5.4% from 2026 to 2036.
  • Top companies in the market include AbbVie Inc., Merck & Co., Inc., and Novartis AG.
  • North America dominated the market in 2025, holding the largest revenue share of 38.7%.
  • By Drug Class, the Antidepressants segment held the major market share of 42.6% in 2025.

Psychotropic Drugs Market By Revenue

Analysts’ Viewpoint regarding Psychotropic Drugs Market

The primary drivers to the expanding psychotropic drugs market include the rising prevalence of mental disorders such as depression, schizophrenia, anxiety, bipolar disorders, ADHD, and the other mental disorders. In addition, the awareness about mental disorders has reduced the stigma related to mental illnesses. The patients thus feel encouraged to undergo treatment.

The expansion of access to healthcare services around the world, especially in emerging markets, and the ability for developed markets to reimburse for many of the drugs through insurance provides additional support for the growth of this market. Furthermore, advancements in the area of drug development has resulted in better treatment outcomes. The demand for psychotropic medications has also increased due to the rising geriatric population, the stress caused by modern-day living, and increased acceptance of long-term medications.

The psychotropic drugs market is witnessing some important trends, which influence the growth of this market. The focus on personalized medicines is increasing, and psychotropic medicines are gradually turning out to be more personalized for patients. More advanced and effective psychotropic medicines, including atypical antipsychotics and new-generation antidepressants, are more favored.

The use of telemedicine and digital health products is making remote diagnosis and treatment of patients using psychotropic medicines easier. Moreover, increased awareness and acceptance of psychotropic drugs have been leading to a growing adoption rate of these products globally. The growing awareness and improved infrastructure in the emerging markets have been leading to a growing adoption of psychotropic drugs in these regions.

Psychotropic Drugs Market Introduction

Psychotropic drugs can be defined as pharmacologic agents whose mechanism of action involves the central nervous system, thereby affecting mental functions such as mood, cognition, perceptions, and behaviors. Psychotropic drugs have found extensive use in the treatment of mental illnesses such as depression, anxiety disorders, schizophrenia, bipolar disorders, and attention deficit/hyperactivity disorder (ADHD).

Attribute Detail
Psychotropic Drugs Market Drivers
  • Rising Prevalence of Mental Health Disorders
  • Growing Adoption of Digital Health Platforms

Rising Prevalence of Mental Health Disorders Anticipated to Boost Psychotropic Drugs Market Share

The rapid increase of mental health issues at a global scale is a significant contributor to the rise in demand for pharmaceutical products. Mental conditions such as anxiety, depression, schizophrenia, and bipolar disorder are rapidly becoming a common problem for individuals across the globe regardless of age. Urbanization, lifestyle changes, pressure at work, social isolation, and increased economic uncertainty have caused an increase in the prevalence of mental health disorders across age groups.

Furthermore, events occurring at the global level, like pandemics, political instability around the world, and more people using digital devices have greatly contributed to higher levels of mental health issues such as depression, anxiety, and stress, thereby creating even more need for effective medication options.

Through raised awareness and educating individuals about mental health, many undiagnosed patients are now receiving mental healthcare. There are many sources of public health initiatives, screening programs, and the media have been instrumental in raising awareness and prompting individuals to seek assistance that have led to increased diagnoses and utilization of psychotropic medications. As a result, mental illness is perceived less negatively, helping to reduce the stigma associated with mental illness and encouraging a growing acceptance for long-term care for mental illnesses in developed nations.

As more people reach old age, their vulnerability to mental impairment, depression, anxiety and neuropsychiatric syndromes due to chronic illness increases. However, increasing awareness about mental illnesses such as ADHD and mood disorders in pediatric patients and adolescents, is increasing the patient base that needs constant pharmacological treatment.

Additionally, the healthcare systems are incorporating mental healthcare in the primary care systems, thus making it easily accessible for diagnosis and treatment. However, the increased burden of mental health conditions is pushing the governments, healthcare systems, and the payers to embrace early intervention and treatment programs. The increased number of patients coupled with the chronicity of the conditions requiring long-term therapy is driving the sustained demand for psychotropic medications.

Growing Adoption of Digital Health Platforms to Drive Psychotropic Drugs Market Expansion

Another major driver that is currently propelling the growth of psychotropic drugs market is the increasing use of digital health platforms. The use of telepsychiatry, mobile health applications, and the other digital health platforms has helped in increasing access to mental health services. The use of these platforms makes it possible for a larger number of patients to be treated as it overcomes geographical and social barriers that may exist in rural areas.

Telepsychiatry is becoming more common and well-accepted, allowing patients to receive care via video conferencing methods, which aids in rapid diagnoses and extended follow-up checks on patients over time. As a result, there has been a significant increase in the number of patients receiving psychotropic medications as patients no longer need to physically visit a doctor to receive treatment for their mental health issues.

There are also digital tools available to assist patients with managing their medications, including e-prescribing, automated notifications, and adherence tracking, which all contribute to improved adherence to treatment regimens and improved overall outcomes from treatment. Improved adherence is necessary for sustained usage of medications and continued growth of the industry.

Further, digital applications for mental health issues have also helped with the early diagnosis of psychiatric symptoms by promoting individuals to seek professional help for their condition during earlier stages of their illness. The data generated from these applications can then be utilized by professionals in the medical field to provide personalized treatment for patients by adapting their medication according to the data collected.

However, the COVID-19 outbreak has accelerated the acceptance and subsequent reimbursements of digital healthcare services, thereby integrating virtual mental healthcare services into mainstream healthcare practices. With the increased investment of the healthcare infrastructure in digital solutions and the rising preference of patients for the convenience of digital healthcare services, the role of digital healthcare platforms in the demand for psychotropic medications will continue to grow.

Attribute Detail
Psychotropic Drugs Market Opportunities
  • Rising Adoption of Long-Acting and Sustained-Release Formulations

Rising Adoption of Long-Acting and Sustained-Release Formulations Poised to Bolster Psychotropic Drugs Market over the Next Decade

The increase in the use of long-acting and sustained release formulations is a substantial opportunity for the psychotropic drugs market as it targets one of the most difficult challenges encountered in psychiatry—patient adherence. Long-acting injectable formulations and sustained-release oral formulations can counter this problem.

Healthcare providers are now utilizing long-acting formulations, especially in the antipsychotic category, at an increasing rate owing to their ability to improve adherence to treatment and decrease rates of relapse as well as decrease the risk of being hospitalized. In addition to these benefits, sustained release technologies have the ability to prevent peaks and troughs of drug concentrations, which allows for better tolerability and fewer side-effects, thus increasing the likelihood of acceptance by patients. The positive impact of these clinical advantages on acceptance will lead to increased adoption by both - hospitals and outpatient providers.

From an industry perspective, long and sustained-release drugs can offer pharmaceutical companies, thereby setting enough room to set them apart from their competitors, extend their patent period, and set a higher price tag as compared to a standard generic drug for the aforementioned drugs. In addition to the fact that in an attempt to offer improved outcomes at a reduced cost of care, the aforementioned drugs can minimize the cost of relapse and emergency care.

The range of psychotropic drugs that can be developed as long-acting formulations is also being expanded through improvements in the technology for delivery of drugs, including depot injection technology and biodegradable polymers. The recognition and approval of guidelines and acceptance by the general population will further increase the use of long-acting and sustained-release psychotropic drugs as it will provide the prescribing doctor with the flexibility to choose among a range of options for prescribing drugs. These factors are expected to contribute to the fast expansion of long-acting and sustained-release psychotropic drugs in the psychotropic drugs market.

Antidepressants Segment Leading Global Psychotropic Drugs Market

Psychotropic Drugs Market By Type

The antidepressants segment dominates the overall psychotropic drugs market, mainly due to the large prevalence of depression and related anxious disorders. Depressive disorders rank among the most common psychiatric conditions (regardless of age), hence creating a substantial patient base for long-term pharmacological management.

Apart from being used to treat depression, anti-depressants are regularly prescribed to treat the other conditions such as anxiety-related disorders and different types of mental health issues, and also as treatment options for certain types of chronic pain. In addition to the improved acceptance of these drug classes due to their good track record for safety and tolerability among physicians and patients, the recent discoveries about how well the general public and insurance companies understand the efficacy of anti-depressant medications will likely result in higher rates of clinical prescribing of antidepressants in the future and strengthen the antidepressant's market dominance further.

Regional Outlook of Psychotropic Drugs Market

Psychotropic Drugs Market By Region

Attribute Detail
Leading Region
  • North America

According to a new market outlook report for next-generation immunology drugs, North America is expected to make up about 38.7% of the total market share in 2025.

North America dominates the psychotropic drug market share due to the combination of a high percentage of the population battling these diseases, the existence of a developed healthcare system that can detect and treat such disorders, and the presence of many more conducive regulatory and reimbursement systems regarding reimbursement for medications. Mental illness screening programs and effective patient education programs have also contributed to a greater demand for psychotropic medications.

With a robust and sophisticated healthcare system and cutting-edge diagnostic and psychiatric care services, both - new and existing psychotropic medications are readily available due to the availability of robust reimbursement and insurance policies, particularly within the U.S. These solid insurance coverage and reimbursement policies help in making these medications affordable and to comply with the use of these medications.

There are a number of leading global pharmaceutical companies and research institutions located in North America, supporting continual innovation and development of new medications. The growth of acceptance for the use of digital health platforms for tele-psychiatrists is increasing access to psychiatric care. This also reinforces North America's leading role in the global psychotropic drugs marketplace.

Analysis of Key Players in Psychotropic Drugs Market

Psychotropic drug companies have placed an increasing focus on innovative products through strategic alliances, thereby developing new generation antidepressants and atypical antipsychotic medications, along with longer-lasting formulations that are effective in treating mental disorders effectively and improving patient compliance.

Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., AstraZeneca, GSK plc, Sage Therapeutics, Inc., Biogen, Noven Therapeutics, LLC., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Abbvie, Bristol-Myers Squibb Company, Sanofi, Cipla Limited, and Sun Pharmaceutical Industries Limited are some of the leading players operating in the global psychotropic drugs market.

Each of these players has been profiled in the psychotropic drugs market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Psychotropic Drugs Market

  • In November 2025, Johnson & Johnson announced that the company received U.S. Food and Drug Administration (FDA) approval for its CAPLYTA (lumateperone) for administration alongside antidepressants as an adjunctive therapy.
  • In September 2025, Biogen Inc. revealed that the company was granted with marketing authorization for ZURZUVAE (zuranolone) by the European Commission (EC) for the treatment of post-partum depression (PPD) in adults following childbirth. The approval was backed by results of the SKYLARK study, which met its primary and secondary endpoints.
  • In January 2025, the U.S. FDA granted Johnson & Johnson approval of a supplemental New Drug Application (sNDA) for the use of SPRAVATO (esketamine) CIII nasal spray for the treatment of adult patients suffering from major depressive disorder (MDD) who have demonstrated inadequate response to at least two oral antidepressants.
  • In September 2024, Bristol-Myers Squibb Company announced the U.S. FDA approval of COBENFY (xanomeline and trospium chloride) for the treatment of adult patients suffering from schizophrenia. The newly approved drug marks the first new class of medicine for schizophrenia management in several decades.

Psychotropic Drugs Market Snapshot

Attribute Detail
Size in 2025 US$ 23.1 Bn
Forecast Value in 2036 US$ 41.2 Bn
CAGR 5.4%
Forecast Period 2026-2036
Historical Data Available for 2021-2024
Quantitative Units US$ Bn
Psychotropic Drugs Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation Drug Class
  • Antidepressants
  • Antipsychotics
  • Anxiolytics
  • Mood Stabilizers
  • Stimulants
  • Sedatives & Hypnotics
  • Others (Cognitive Enhancers & Nootropics, etc.)
Drug Type
  • Branded
  • Generic
Indication
  • Depression
  • Schizophrenia
  • Bipolar Disorder
  • Anxiety Disorders
  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Post-Traumatic Stress Disorder (PTSD)
  • Obsessive-Compulsive Disorder (OCD)
  • Others (Insomnia, etc.)
Route of Administration
  • Oral
  • Injectable
  • Transdermal
  • Others (Intranasal, etc.)
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • Australia & New Zealand
  • India
  • Japan
  • South Korea
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Johnson & Johnson
  • Eli Lilly and Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • GSK plc
  • Sage Therapeutics, Inc.
  • Biogen
  • Noven Therapeutics, LLC.
  • Otsuka Pharmaceutical Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Abbvie
  • Bristol-Myers Squibb Company
  • Sanofi
  • Cipla Limited
  • Sun Pharmaceutical Industries Limited
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global psychotropic drugs market in 2025?

The global psychotropic drugs market was valued at US$ 23.1 Bn in 2025

How big will the global psychotropic drugs industry be in 2036?

The global psychotropic drugs industry is projected to reach more than US$ 41.2 Bn by the end of 2036

What are the factors driving the psychotropic drugs market?

Rising prevalence and diagnosis of mental health disorders, advancements in drug development, favorable reimbursement and insurance coverage, and better access to care and prescribing channels are some of the factors driving the expansion of psychotropic drugs market.

What will be the CAGR of the global psychotropic drugs industry during the forecast period?

The CAGR is anticipated to be 5.4% from 2026 to 2036

Who are the prominent players in the global psychotropic drugs market?

Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., AstraZeneca, GSK plc, Sage Therapeutics, Inc., Biogen, Noven Therapeutics, LLC., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Abbvie, Bristol-Myers Squibb Company, Sanofi, Cipla Limited, and Sun Pharmaceutical Industries Limited

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Psychotropic Drugs Market
  4. Market Overview
    • Introduction
      • Segment Definition
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Psychotropic Drugs Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • Healthcare Expenditure across Key Countries / Regions
    • Technological and Product Innovation Trends
    • Clinical Trial Analysis
    • Regulatory Scenario across Key Regions / Countries
    • Reimbursement Landscape across Key Regions / Countries
    • Supply Chain & Procurement Insights
    • PORTER’s Five Forces Analysis
    • PESTLE Analysis
    • Go-to-Market Strategy for New Market Entrants
    • Key Purchase Metrics for End-users
    • Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
    • Benchmarking of the Products Offered by the Leading Competitors
  6. Global Psychotropic Drugs Market Analysis and Forecast, by Drug Class
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Attractiveness Analysis, by Drug Class
  7. Global Psychotropic Drugs Market Analysis and Forecast, by Drug Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Attractiveness Analysis, by Drug Type
  8. Global Psychotropic Drugs Market Analysis and Forecast, by Indication
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Attractiveness Analysis, by Indication
  9. Global Psychotropic Drugs Market Analysis and Forecast, by Route of Administration
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Attractiveness Analysis, by Route of Administration
  10. Global Psychotropic Drugs Market Analysis and Forecast, by Distribution Channel
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis, by Distribution Channel
  11. Global Psychotropic Drugs Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  12. North America Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Value Forecast, by Country, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
      • By Country
  13. U.S. Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  14. Canada Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  15. Europe Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
      • By Country/Sub-region
  16. Germany Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  17. UK Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  18. France Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  19. Italy Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  20. Spain Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  21. The Netherlands Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  22. Rest of Europe Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  23. Asia Pacific Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • ASEAN
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
      • By Country/Sub-region
  24. China Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  25. India Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  26. Japan Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  27. South Korea Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  28. Australia & New Zealand Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  29. ASEAN Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  30. Rest of Asia Pacific Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  31. Latin America Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
      • By Country/Sub-region
  32. Brazil Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  33. Argentina Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  34. Mexico Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  35. Rest of Latin America Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  36. Middle East & Africa Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
      • By Country/Sub-region
  37. GCC Countries Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  38. South Africa Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  39. Rest of Middle East & Africa Psychotropic Drugs Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Drug Class, 2021-2036
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Mood Stabilizers
      • Stimulants
      • Sedatives & Hypnotics
      • Others
    • Market Value Forecast, by Drug Type, 2021-2036
      • Branded
      • Generic
    • Market Value Forecast, by Indication, 2021-2036
      • Depression
      • Schizophrenia
      • Bipolar Disorder
      • Anxiety Disorders
      • Attention-Deficit/Hyperactivity Disorder (ADHD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Obsessive-Compulsive Disorder (OCD)
      • Others
    • Market Value Forecast, by Route of Administration, 2021-2036
      • Oral
      • Injectable
      • Transdermal
      • Others
    • Market Value Forecast, by Distribution Channel, 2021-2036
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Attractiveness Analysis
      • By Drug Class
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Distribution Channel
  40. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2024)
    • Company Profiles
      • Johnson & Johnson
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Eli Lilly and Company
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Pfizer Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Merck & Co., Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • AstraZeneca
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • GSK plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sage Therapeutics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Biogen
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Noven Therapeutics, LLC.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Takeda Pharmaceutical Company Limited
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Abbvie
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bristol-Myers Squibb Company
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sanofi
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Cipla Limited
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sun Pharmaceutical Industries Limited
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Other Prominent Players

List of Tables

Table 01: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 02: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 03: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 04: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 05: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 06: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, By Region, 2021 to 2036
Table 07: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, by Country, 2021-2036
Table 08: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 09: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 10: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 11: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 12: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 13: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 14: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 15: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 16: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 17: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 18: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 19: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 20: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 21: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 22: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 23: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 24: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 25: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 26: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 27: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 28: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 29: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 30: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 31: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 32: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 33: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 34: U.K. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 35: U.K. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 36: U.K. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 37: U.K. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 38: U.K. Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 39: France Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 40: France Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 41: France Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 42: France Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 43: France Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 44: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 45: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 46: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 47: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 48: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 49: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 50: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 51: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 52: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 53: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 54: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 55: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 56: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 57: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 58: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 59: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 60: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 61: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 62: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 63: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 64: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 65: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 66: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 67: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 68: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 69: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 70: China Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 71: China Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 72: China Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 73: China Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 74: China Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 75: India Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 76: India Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 77: India Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 78: India Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 79: India Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 80: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 81: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 82: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 83: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 84: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 85: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 86: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 87: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 88: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 89: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 90: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 91: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 92: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 93: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 94: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 95: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 96: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 97: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 98: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 99: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 100: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 101: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 102: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 103: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 104: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 105: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 106: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 107: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 108: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 109: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 110: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 111: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 112: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 113: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 114: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 115: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 116: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 117: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 118: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 119: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 120: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 121: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 122: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 123: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 124: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 125: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 126: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 127: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 128: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 129: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 130: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 131: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 132: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 133: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 134: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 135: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 136: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 137: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 138: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 139: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 140: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 141: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 142: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 143: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 144: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 145: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 146: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 147: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Class, 2021 to 2036
Table 148: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 149: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Indication, 2021 to 2036
Table 150: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 151: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036

List of Figures

Figure 01: Global Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 02: Global Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 03: Global Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 04: Global Psychotropic Drugs Market Revenue (US$ Bn), by Antidepressants, 2021 to 2036
Figure 05: Global Psychotropic Drugs Market Revenue (US$ Bn), by Antipsychotics, 2021 to 2036
Figure 06: Global Psychotropic Drugs Market Revenue (US$ Bn), by Anxiolytics, 2021 to 2036
Figure 07: Global Psychotropic Drugs Market Revenue (US$ Bn), by Mood Stabilizers, 2021 to 2036
Figure 08: Global Psychotropic Drugs Market Revenue (US$ Bn), by Stimulants, 2021 to 2036
Figure 09: Global Psychotropic Drugs Market Revenue (US$ Bn), by Sedatives & Hypnotics, 2021 to 2036
Figure 10: Global Psychotropic Drugs Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 11: Global Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 12: Global Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 13: Global Psychotropic Drugs Market Revenue (US$ Bn), by Branded, 2021 to 2036
Figure 14: Global Psychotropic Drugs Market Revenue (US$ Bn), by Generic, 2021 to 2036
Figure 15: Global Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 16: Global Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 17: Global Psychotropic Drugs Market Revenue (US$ Bn), by Depression, 2021 to 2036
Figure 18: Global Psychotropic Drugs Market Revenue (US$ Bn), by Schizophrenia, 2021 to 2036
Figure 19: Global Psychotropic Drugs Market Revenue (US$ Bn), by Bipolar Disorder, 2021 to 2036
Figure 20: Global Psychotropic Drugs Market Revenue (US$ Bn), by Anxiety Disorders, 2021 to 2036
Figure 21: Global Psychotropic Drugs Market Revenue (US$ Bn), by Attention-Deficit/Hyperactivity Disorder (ADHD), 2021 to 2036
Figure 22: Global Psychotropic Drugs Market Revenue (US$ Bn), by Post-Traumatic Stress Disorder (PTSD), 2021 to 2036
Figure 23: Global Psychotropic Drugs Market Revenue (US$ Bn), by Obsessive-Compulsive Disorder (OCD), 2021 to 2036
Figure 24: Global Psychotropic Drugs Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 25: Global Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 26: Global Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 27: Global Psychotropic Drugs Market Revenue (US$ Bn), by Oral, 2021 to 2036
Figure 28: Global Psychotropic Drugs Market Revenue (US$ Bn), by Injectable, 2021 to 2036
Figure 29: Global Psychotropic Drugs Market Revenue (US$ Bn), by Transdermal, 2021 to 2036
Figure 30: Global Psychotropic Drugs Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 31: Global Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 32: Global Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 33: Global Psychotropic Drugs Market Revenue (US$ Bn), by Hospital Pharmacies, 2021 to 2036
Figure 34: Global Psychotropic Drugs Market Revenue (US$ Bn), by Retail Pharmacies, 2021 to 2036
Figure 35: Global Psychotropic Drugs Market Revenue (US$ Bn), by Online Pharmacies, 2021 to 2036
Figure 36: Global Psychotropic Drugs Market Value Share Analysis, by Region, 2025 and 2036
Figure 37: Global Psychotropic Drugs Market Attractiveness Analysis, by Region, 2026 to 2036
Figure 38: North America Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 39: North America Psychotropic Drugs Market Value Share Analysis, by Country, 2025 and 2036
Figure 40: North America Psychotropic Drugs Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 41: North America Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 42: North America Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 43: North America Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 44: North America Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 45: North America Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 46: North America Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 47: North America Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 48: North America Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 49: North America Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 50: North America Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 51: U.S. Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 52: U.S. Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 53: U.S. Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 54: U.S. Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 55: U.S. Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 56: U.S. Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 57: U.S. Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 58: U.S. Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 59: U.S. Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 60: U.S. Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 61: U.S. Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 62: Canada Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 63: Canada Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 64: Canada Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 65: Canada Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 66: Canada Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 67: Canada Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 68: Canada Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 69: Canada Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 70: Canada Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 71: Canada Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 72: Canada Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 73: Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 74: Europe Psychotropic Drugs Market Value Share Analysis, by Country / Sub-region, 2025 and 2036
Figure 75: Europe Psychotropic Drugs Market Attractiveness Analysis, by Country / Sub-region, 2026 to 2036
Figure 76: Europe Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 77: Europe Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 78: Europe Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 79: Europe Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 80: Europe Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 81: Europe Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 82: Europe Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 83: Europe Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 84: Europe Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 85: Europe Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 86: Germany Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 87: Germany Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 88: Germany Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 89: Germany Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 90: Germany Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 91: Germany Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 92: Germany Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 93: Germany Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 94: Germany Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 95: Germany Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 96: Germany Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 97: UK Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 98: UK Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 99: UK Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 100: UK Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 101: UK Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 102: UK Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 103: UK Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 104: UK Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 105: UK Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 106: UK Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 107: UK Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 108: France Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 109: France Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 110: France Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 111: France Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 112: France Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 113: France Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 114: France Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 115: France Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 116: France Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 117: France Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 118: France Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 119: Italy Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 120: Italy Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 121: Italy Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 122: Italy Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 123: Italy Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 124: Italy Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 125: Italy Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 126: Italy Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 127: Italy Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 128: Italy Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 129: Italy Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 130: Spain Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 131: Spain Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 132: Spain Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 133: Spain Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 134: Spain Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 135: Spain Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 136: Spain Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 137: Spain Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 138: Spain Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 139: Spain Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 140: Spain Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 141: The Netherlands Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 142: The Netherlands Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 143: The Netherlands Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 144: The Netherlands Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 145: The Netherlands Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 146: The Netherlands Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 147: The Netherlands Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 148: The Netherlands Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 149: The Netherlands Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 150: The Netherlands Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 151: The Netherlands Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 152: Rest of Europe Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 153: Rest of Europe Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 154: Rest of Europe Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 155: Rest of Europe Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 156: Rest of Europe Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 157: Rest of Europe Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 158: Rest of Europe Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 159: Rest of Europe Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 160: Rest of Europe Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 161: Rest of Europe Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 162: Rest of Europe Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 163: Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 164: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Country / Sub-region, 2025 and 2036
Figure 165: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Country / Sub-region, 2026 to 2036
Figure 166: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 167: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 168: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 169: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 170: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 171: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 172: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 173: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 174: Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 175: Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 176: China Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 177: China Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 178: China Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 179: China Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 180: China Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 181: China Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 182: China Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 183: China Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 184: China Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 185: China Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 186: China Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 187: India Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 188: India Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 189: India Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 190: India Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 191: India Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 192: India Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 193: India Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 194: India Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 195: India Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 196: India Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 197: India Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 198: Japan Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 199: Japan Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 200: Japan Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 201: Japan Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 202: Japan Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 203: Japan Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 204: Japan Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 205: Japan Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 206: Japan Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 207: Japan Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 208: Japan Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 209: South Korea Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 210: South Korea Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 211: South Korea Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 212: South Korea Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 213: South Korea Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 214: South Korea Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 215: South Korea Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 216: South Korea Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 217: South Korea Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 218: South Korea Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 219: South Korea Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 220: ASEAN Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 221: ASEAN Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 222: ASEAN Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 223: ASEAN Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 224: ASEAN Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 225: ASEAN Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 226: ASEAN Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 227: ASEAN Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 228: ASEAN Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 229: ASEAN Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 230: ASEAN Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 231: Australia & New Zealand Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 232: Australia & New Zealand Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 233: Australia & New Zealand Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 234: Australia & New Zealand Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 235: Australia & New Zealand Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 236: Australia & New Zealand Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 237: Australia & New Zealand Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 238: Australia & New Zealand Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 239: Australia & New Zealand Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 240: Australia & New Zealand Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 241: Australia & New Zealand Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 242: Rest of Asia Pacific Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 243: Rest of Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 244: Rest of Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 245: Rest of Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 246: Rest of Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 247: Rest of Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 248: Rest of Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 249: Rest of Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 250: Rest of Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 251: Rest of Asia Pacific Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 252: Rest of Asia Pacific Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 253: Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 254: Latin America Psychotropic Drugs Market Value Share Analysis, by Country / Sub-region, 2025 and 2036
Figure 255: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Country / Sub-region, 2026 to 2036
Figure 256: Latin America Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 257: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 258: Latin America Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 259: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 260: Latin America Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 261: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 262: Latin America Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 263: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 264: Latin America Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 265: Latin America Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 266: Brazil Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 267: Brazil Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 268: Brazil Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 269: Brazil Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 270: Brazil Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 271: Brazil Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 272: Brazil Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 273: Brazil Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 274: Brazil Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 275: Brazil Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 276: Brazil Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 277: Argentina Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 278: Argentina Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 279: Argentina Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 280: Argentina Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 281: Argentina Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 282: Argentina Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 283: Argentina Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 284: Argentina Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 285: Argentina Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 286: Argentina Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 287: Argentina Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 288: Mexico Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 289: Mexico Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 290: Mexico Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 291: Mexico Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 292: Mexico Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 293: Mexico Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 294: Mexico Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 295: Mexico Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 296: Mexico Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 297: Mexico Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 298: Mexico Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 299: Rest of Latin America Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 300: Rest of Latin America Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 301: Rest of Latin America Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 302: Rest of Latin America Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 303: Rest of Latin America Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 304: Rest of Latin America Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 305: Rest of Latin America Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 306: Rest of Latin America Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 307: Rest of Latin America Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 308: Rest of Latin America Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 309: Rest of Latin America Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 310: Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 311: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Country / Sub-region, 2025 and 2036
Figure 312: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Country / Sub-region, 2026 to 2036
Figure 313: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 314: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 315: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 316: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 317: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 318: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 319: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 320: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 321: Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 322: Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 323: GCC Countries Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 324: GCC Countries Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 325: GCC Countries Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 326: GCC Countries Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 327: GCC Countries Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 328: GCC Countries Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 329: GCC Countries Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 330: GCC Countries Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 331: GCC Countries Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 332: GCC Countries Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 333: GCC Countries Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 334: South Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 335: South Africa Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 336: South Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 337: South Africa Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 338: South Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 339: South Africa Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 340: South Africa Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 341: South Africa Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 342: South Africa Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 343: South Africa Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 344: South Africa Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 345: Rest of Middle East & Africa Psychotropic Drugs Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 346: Rest of Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 347: Rest of Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 348: Rest of Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Drug Type, 2025 and 2036
Figure 349: Rest of Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Drug Type, 2026 to 2036
Figure 350: Rest of Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Indication, 2025 and 2036
Figure 351: Rest of Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 352: Rest of Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 353: Rest of Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 354: Rest of Middle East & Africa Psychotropic Drugs Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 355: Rest of Middle East & Africa Psychotropic Drugs Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Psychotropic Drugs Market

Buy This ReportBuy Now